Journal for ImmunoTherapy of Cancer (Nov 2023)
218 Prospective spatial immune cell profiling identifies features of the tumor-immune microenvironment associated with genomic alterations and patient survival in a 2,023 patient pan-cancer cohort
- Sara M Tolaney,
- James Lindsay,
- Michael Manos,
- Biagio Ricciuti,
- Anita Giobbie-Hurder,
- Scott J Rodig,
- Joao V Alessi,
- Mark M Awad,
- Sandro Santagata,
- Bruce E Johnson,
- Glenn J Hanna,
- Elio Adib,
- Jason Weirather,
- Xinan Wang,
- Bijaya Sharma,
- Kathleen Pfaff,
- Kristen D Felt,
- William Lotter,
- Panagiotis Konstantinopoulos,
- Madison Turner,
- Federica Pecci,
- Emma L Welsh,
- Stephanie M Jones,
- Jennifer O Altreuter,
- Ian D Dryg,
- Alessandro Di Federico,
- Malini M Gandhi,
- Sabrina J Chan,
- Marta Holovatska,
- Melissa E Hughes,
- O’Meara Tess A,
- Neal I Lindeman,
- Jennifer Curtis,
- Peter K Sorger,
- Ethan Cerami,
- Lynette M Sholl,
- Jonathan A Novak
Affiliations
- Sara M Tolaney
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- James Lindsay
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Michael Manos
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Biagio Ricciuti
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Anita Giobbie-Hurder
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Scott J Rodig
- 2Brigham and Women’s Hospital, Boston, MA, USA
- Joao V Alessi
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Mark M Awad
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Sandro Santagata
- 4Harvard Medical School, Boston, MA, USA
- Bruce E Johnson
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Glenn J Hanna
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Elio Adib
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Jason Weirather
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Xinan Wang
- 3Harvard T.H. Chan School of Public Health, Boston, MA, USA
- Bijaya Sharma
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Kathleen Pfaff
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Kristen D Felt
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- William Lotter
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Panagiotis Konstantinopoulos
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Madison Turner
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Federica Pecci
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Emma L Welsh
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Stephanie M Jones
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Jennifer O Altreuter
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Ian D Dryg
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Alessandro Di Federico
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Malini M Gandhi
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Sabrina J Chan
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Marta Holovatska
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Melissa E Hughes
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- O’Meara Tess A
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Neal I Lindeman
- 2Brigham and Women’s Hospital, Boston, MA, USA
- Jennifer Curtis
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Peter K Sorger
- 4Harvard Medical School, Boston, MA, USA
- Ethan Cerami
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- Lynette M Sholl
- 12Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
- Jonathan A Novak
- 2Brigham and Women’s Hospital, Boston, MA, USA
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.0218
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.